Asia-Pacific Study of Transcatheter Mitral and Tricuspid Valve-in-Valve and Valve-in-Ring Procedures

What this Trial Is About

Researchers are conducting a retrospective and prospective observational study involving patients who have undergone or are planning to undergo transcatheter mitral or tricuspid valve-in-valve or valve-in-ring procedures with balloon expandable valves. This multicenter cohort study takes place across various sites in the Asia-Pacific region and aims to collect detailed information about these valve procedures in patients with heart valve disease. The study includes four groups of patients those who have had or will have a mitral valve-in-valve procedure, a mitral valve-in-ring procedure, a tricuspid valve-in-valve procedure, or a tricuspid valve-in-ring procedure. These procedures involve the placement of balloon expandable valves in the mitral or tricuspid positions either within an existing valve valve-in-valve or within a ring valve-in-ring. Participants will be followed up to measure all-cause mortality from the date of their procedure for up to 10 years. Data will be collected retrospectively for past procedures since January 1, 2023, and prospectively for planned procedures. This long-term follow-up will help researchers understand outcomes after these specific valve procedures. Participants can expect their health status to be monitored over time with no additional intervention as part of this observational registry.

The Asia-Pacific Mitral & Tricuspid Valve-in-Valve/Valve-in-Ring Registry (AP ViV Registry)